Compass Capital Management, Inc Novartis Ag Transaction History

Compass Capital Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 31, 2018	SELL	$66.94 - $77.43 $22.4 Million - $25.9 Million	-333,890 Closed	0 $0
Q2 2018 Jul 20, 2018	BUY	$64.91 - $73.36 $1.88 Million - $2.12 Million	28,959 Added 9.5%	333,890 $25.2 Million
Q1 2018 Apr 27, 2018	BUY	$70.39 - $84.15 $799,771 - $956,112	11,362 Added 3.87%	304,931 $24.7 Million
Q4 2017 Jan 30, 2018	BUY	$72.33 - $77.64 $703,843 - $755,514	9,731 Added 3.43%	293,569 $24.6 Million
Q3 2017 Nov 01, 2017	BUY	$74.14 - $77.27 $21 Million - $21.9 Million	283,838	283,838 $24.4 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Compass Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Compass Capital Management, Inc with notifications on news.